Sanofi boosts its mRNA capabilities with Translate Bio acquisition
3rd August 2021 Uncategorised 0Sanofi will acquire Translate Bio for approximately $3.2bn, or $38.00 per share in cash
More: Sanofi boosts its mRNA capabilities with Translate Bio acquisition
Source: News